The first healthy volunteer has been dosed in a Phase 1 study of Cellarity's novel globin-switching therapy CLY-124 for ...

Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...

"Vertex reports long-term results for Casgevy in sickle cell and thalassaemia" was originally created and published by ...

As a result of being a caregiver for her cousin, columnist Sylvia Amuta says she's now more caring, compassionate, and kind to others.

Sickle cell disease affects about 100,000 people in the U.S., and 90% of patients are Black, according to NIH.